News

Hosted on MSN11d
Medicare Will Not Cover GLP-1 Drugs for Weight Loss
The Centers for Medicare and Medicaid Services recently announced—without explanation—that it would not proceed with a ...
Plan to cover anti-obesity drugs through Medicare is dropped
The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...
Pharmaceutical Technology on MSN12d
Obesity drugs won’t be covered by Medicare under 2026 CMS policy
The CMS has opted not to move forward with a plan that would have extended Medicare coverage to obesity drugs for millions of ...
Patients Cut Off From Cheaper Obesity Drugs as the F.D.A. Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
The Associated Press on MSN13d
Rising cost of weight-loss drugs has state Medicaid programs looking for solution
Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...
Medscape8d
4 Things Docs Should Know About New Medicare Advantage Rules
Prior authorization leeway will be trimmed while health plans get more money under new federal rules for Medicare Advantage ...
PhillyVoice9d
Sen. Fetterman urges Trump not to abandon plan for Medicare, Medicaid coverage of weight-loss drugs
In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...
Trump's executive order seeks to lower prescription drugs prices, including Medicare patients
President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...